Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy.
Masahiro TaharaKeishi OdaKei YamasakiTakako KawaguchiKonomi SennariShingo NoguchiNoriho SakamotoToshinori KawanamiHiroshi MukaeKazuhiro YateraPublished in: BMC pulmonary medicine (2019)
We found differential effects of nintedanib on PH between IPF patients with or without LTOT. Nintedanib may have a disadvantageous effect on PH in IPF patients with LTOT. Conversely, nintedanib treatment may be beneficial to PH in IPF patients without LTOT.
Keyphrases
- idiopathic pulmonary fibrosis
- pulmonary hypertension
- interstitial lung disease
- ejection fraction
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- left ventricular
- pulmonary artery
- stem cells
- pulmonary arterial hypertension
- rheumatoid arthritis
- combination therapy
- mesenchymal stem cells
- smoking cessation